Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited (LPL) is engaged in the business of manufacturing, marketing and distribution of pharmaceutical products.

Pros:
Company has good consistent profit growth of 33.18% over 5 years
Cons:
Promoter's stake has decreased
Promoter holding is low: 32.39%

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Formulations

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Mar 2016 Jun 2016 Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018
119.99 89.16 74.27 70.29 118.85 149.56 89.65 80.18 67.34 99.82 102.60 84.43
116.99 74.06 62.72 61.65 115.06 142.54 74.21 64.02 57.69 76.53 83.52 70.82
Operating Profit 3.00 15.10 11.55 8.64 3.79 7.02 15.44 16.16 9.65 23.29 19.08 13.61
OPM % 2.50% 16.94% 15.55% 12.29% 3.19% 4.69% 17.22% 20.15% 14.33% 23.33% 18.60% 16.12%
Other Income 8.52 3.54 3.41 3.27 0.21 2.84 2.99 2.83 0.86 2.30 4.43 0.38
Interest 4.08 2.12 1.77 1.35 1.42 1.61 1.50 1.37 0.94 1.33 1.75 0.71
Depreciation 1.29 1.38 1.28 1.46 1.39 1.38 1.81 1.39 1.53 1.58 1.51 1.94
Profit before tax 6.15 15.14 11.91 9.10 1.19 6.87 15.12 16.23 8.04 22.68 20.25 11.34
Tax % 33.50% 24.70% 25.78% 27.91% -11.76% 28.38% 25.13% 28.59% 15.05% 29.10% 25.93% 19.40%
Net Profit 4.02 11.39 8.84 6.54 1.27 4.91 11.30 11.58 6.83 16.07 15.00 9.15
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 TTM
114 124 176 188 195 210 266 400 360 361 354
104 113 167 174 179 190 240 359 313 308 289
Operating Profit 10 11 10 14 15 20 26 41 47 53 66
OPM % 9% 9% 5% 7% 8% 10% 10% 10% 13% 15% 19%
Other Income -1 1 3 3 6 2 7 7 2 5 8
Interest 2 3 5 8 8 7 8 10 7 5 5
Depreciation 1 1 2 2 3 4 5 5 6 6 7
Profit before tax 7 9 6 7 11 12 20 33 37 46 62
Tax % 35% 29% 33% 30% 16% 16% 24% 28% 25% 25%
Net Profit 4 6 4 5 10 11 15 24 28 35 47
EPS in Rs 27.25 5.20 2.46 3.04 5.82 6.43 9.00 14.32 14.06 17.31
Dividend Payout % 21% 22% 23% 19% 10% 9% 11% 7% 9% 9%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:%
5 Years:13.12%
3 Years:10.67%
TTM:-19.18%
Compounded Profit Growth
10 Years:%
5 Years:33.18%
3 Years:33.15%
TTM:61.91%
Return on Equity
10 Years:%
5 Years:16.27%
3 Years:17.67%
TTM:16.69%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Sep 2018
8 11 16 16 16 16 16 16 20 20 20
Reserves 28 42 60 64 73 82 95 117 172 204 232
Borrowings 16 27 44 65 76 68 76 78 64 61 37
22 31 44 66 72 93 70 64 53 64 85
Total Liabilities 73 111 165 212 237 260 258 275 310 350 373
17 21 28 38 65 65 66 98 103 117 109
CWIP 0 1 4 14 2 2 3 3 7 0 1
Investments 0 0 0 0 0 0 0 0 10 11 14
56 89 133 161 169 192 190 174 190 222 250
Total Assets 73 111 165 212 237 260 258 275 310 350 373

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
2 -11 -34 12 -16 5 25 45 25 23
-4 -6 -11 -27 -16 1 7 -42 -25 -8
3 25 45 16 29 -11 -32 -3 0 -11
Net Cash Flow 1 9 -0 1 -3 -4 -1 -0 -0 3

Ratios Consolidated / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018
ROCE % 17% 10% 10% 11% 12% 16% 22% 19% 19%
Debtor Days 74 92 83 127 140 154 163 73 92 111
Inventory Turnover 6.67 7.20 7.90 9.56 9.75 11.65 16.23 11.12 8.72

Recent Announcements

View all announcements

Annual Reports

Credit Ratings